A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease

PHASE3RecruitingINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

June 16, 2023

Primary Completion Date

March 8, 2030

Study Completion Date

May 30, 2031

Conditions
Crohn's Disease
Interventions
DRUG

Vedolizumab IV

Vedolizumab IV infusion

DRUG

Placebo

Vedolizumab placebo-matching IV infusion

Trial Locations (40)

100034

NOT_YET_RECRUITING

Peking University First Hospital, Beijing

100191

RECRUITING

Peking University Third Hospital, Beijing

110004

RECRUITING

Shengjing Hospital of China Medical University, Shenyang

150001

NOT_YET_RECRUITING

The 2nd Affliated Hospital of Harbin Medical University, Harbin

200032

NOT_YET_RECRUITING

Zhongshan Hospital Fudan University, Shanghai

200123

RECRUITING

Shanghai East Hospital, Shanghai

200433

RECRUITING

Shanghai Changhai Hospital, Shanghai

210009

RECRUITING

Zhongda Hospital, Affiliated to Southeast University, Nanjing

213200

RECRUITING

Changzhou No.2 People's Hospital, Changzhou

215516

RECRUITING

Changshu No.2 People's Hospital, Suzhou

221000

NOT_YET_RECRUITING

Xuzhou Central Hospital, Xuzhou

230601

RECRUITING

The Second Hospital of Anhui Medical University, Hefei

241001

RECRUITING

Yijishan Hospital of Wannan Medical College, Wuhu

264000

NOT_YET_RECRUITING

Yantai Yuhuangding Hospital, Yantai

300052

RECRUITING

Tianjin Medical University General Hospital, Tianjin

310003

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine - PPDS, Hangzhou

315010

RECRUITING

The First Affiliated Hospital of Ningbo University(Ningbo First Hospital), Ningbo

317602

RECRUITING

Taizhou Hospital of Zhejiang Province, Taizhou

324307

RECRUITING

People's Hospital of Quzhou, Quzhou

325000

NOT_YET_RECRUITING

The 1st Affiliated Hospital of Wenzhou Medical University, Wenzhou

330008

RECRUITING

The Second Affiliated Hospital of Nanchang University, Nanchang

350005

NOT_YET_RECRUITING

The First Affiliated Hospital of Fujian Medical University, Fuzhou

430022

RECRUITING

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

430060

NOT_YET_RECRUITING

Renmin Hospital of Wuhan University, Wuhan

474500

NOT_YET_RECRUITING

Nanyang First People's Hospital, Nanyang

510080

RECRUITING

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

510180

RECRUITING

Guangzhou First People's Hospital, Guangzhou

510260

RECRUITING

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

510630

RECRUITING

The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou

510655

RECRUITING

The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou

511518

RECRUITING

Qingyuan Peoples Hospital, Qingyuan

516001

RECRUITING

Huizhou Central People's Hospital, Huizhou

518053

RECRUITING

The University of Hong Kong - Shenzhen Hospital, Shenzhen

519000

RECRUITING

The Fifth Affiliated Hospital Sun Yat-Sen University, Zhuhai

528000

RECRUITING

The First People's Hospital of Foshan, Foshan

530021

NOT_YET_RECRUITING

The First Affiliated Hospital of Guangxi Medical University, Nanning

650100

RECRUITING

The First People's Hospital of Yunnan Province, Kunming

730030

RECRUITING

Lanzhou University Second Hospital, Lanzhou

750002

NOT_YET_RECRUITING

People's Hospital of Ningxia Hui Aotonomous Region, Yinchuan

050051

RECRUITING

The Second Hospital of Hebei Medical University, Shijiazhuang

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY